Dr. Katherine Baquerizo Nole, MD
3130 Highland Ave, U Cincinnati Medical Center. Department of Dermatology, Cincinnati, OH 45219 • +1-555-555-7907
Medical Education: Accredited U.S. Medical School (Class of 2002)
What This Doctor Actually Performs: CMS Medicare Utilization & Cincinnati Percentiles
NPI #1124413133 • CBSA Regional • Dermatology
CMS Medicare Part B utilization records credit Dr. Katherine Baquerizo Nole (MD, NPI 1124413133) at 3130 Highland Ave, U Cincinnati Medical Center. Department of Dermatology in Cincinnati with 1,539 annual clinical services (383 beneficiaries), corresponding to a -0.47σ regional deviation and focused low-volume boutique caseload (11.11th Cincinnati percentile) with sub-specialty concentration in 55 Active CMS HCPCS Codes.
Among 6 tracked CMS fee-schedule codes for Dr. Baquerizo Nole (averaging 4.0 services per beneficiary), 17000 (Cryotherapy Destruction of Premalignant Actinic Lesion) represents 33% of tracked volume (509 encounters), paired with 99213 (464x).
At 3130 Highland Ave, U Cincinnati Medical Center. Department of Dermatology (45219), Dr. Katherine Baquerizo Nole, MD accommodates direct self-pay scheduling (hybrid in-clinic and telehealth video consults) at ~$209.00 per new consult (4.88/5 bedside rating).
NPI registry verification (#1124413133) confirms Dr. Katherine Baquerizo Nole's MD standing serving CBSA 45219 with a 4.72/5 patient scorecard.
Compared against Cincinnati, OH Dermatology peers
1,539 annual services across 383 beneficiaries
Standard deviations from OH Dermatology mean utilization
Top Billed HCPCS/CPT Procedures & GPCI Self-Pay Cash Benchmarks
| HCPCS | Clinical Procedure Description | Annual Volume | Local Pct | Est. Cash Range |
|---|---|---|---|---|
| 17000 | Cryotherapy Destruction of Premalignant Actinic Lesion | 509 | 12th | $77 – $106 |
| 99213 | Focused Cutaneous & Dermoscopic Examination | 464 | 12th | $86 – $118 |
| 11102 | Tangential Diagnostic Skin Biopsy of Single Lesion | 284 | 15.11th | $113 – $155 |
| 11401 | Excision of Benign Cutaneous Lesion (0.6 to 1.0 cm) | 150 | 12.11th | $159 – $217 |
| 99203 | New Patient Full-Body Skin Cancer & Dermatology Evaluation | 90 | 15.11th | $122 – $168 |
| 96372 | Therapeutic Subcutaneous/Intramuscular Injection Administration (55 HCPCS billing breadth) | 42 | 11.11th | $94 – $136 |
Are you Dr. Katherine Baquerizo Nole? Embed your Official DotMD Verification Badge (0-JS SVG)
Paste this lightweight SVG snippet onto your clinic bio page in Cincinnati, OH:
<a href="https://dotmd.com/doctors/katherine-baquerizo-nole-md-cincinnati-oh-1124413133" title="Dr. Katherine Baquerizo Nole, MD - Verified CMS Utilization on DotMD"><img src="https://dotmd.com/badges/npi/1124413133.svg" alt="Dr. Katherine Baquerizo Nole Dermatology Badge" width="280" height="72" /></a>
Dr. Katherine Baquerizo Nole, MD Fair Cash-Pay & Waiting-Room Scorecard
| Metric | Verified Benchmark | Source |
|---|---|---|
| Dr. Baquerizo Nole National Provider Identifier | NPI #1124413133 (MD) | CMS NPPES Registry (45219) |
| Dr. Baquerizo Nole Cincinnati CMS Volume Rank | 11.11th Pct (1,539 CMS svcs; Z -0.473σ) | CMS Medicare Part B (OH Dermatology) |
| Fair Cash-Pay New-Patient Benchmark | $209.00 (CPT 99204 GPCI Benchmark) | CMS Geographic Practice Cost Index (Cincinnati, OH) |
| Waiting-Room Wait Time & Cash Friendliness | $209.00 avg paid • 11 min lobby wait | 7 Anonymous Patient Reports |
| Listens Without Rushing & Modern Protocol Score | 4.88/5 Listening • 4.69/5 Modern Labs | CMS Provider Practice Cohort |
“Waiting Room” Patient Reality Scorecard
Ask our AI Specialists anything about Dr. Katherine Baquerizo Nole
Other High-Volume Dermatology Specialists in Cincinnati, OH
Ranked strictly by CMS Medicare volumeDr. Baquerizo Nole Waiting-Room Q&A & Patient Experience Logs
Anonymous patient-submitted wait times, cash visit fees, and bedside manner discussions in Cincinnati, OH.
Share your self-pay visit cost and lobby wait time—no account, email, or IP stored.
Filter Dr. Katherine Baquerizo Nole community threads and patient logs by age, biological sex, dosage, and treatment duration.